MYALEPT Trademark

Trademark Overview

On Wednesday, August 21, 2013, a trademark application was filed for MYALEPT with the United States Patent and Trademark Office. The USPTO has given the MYALEPT trademark a serial number of 86043958. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 22, 2020. This trademark is owned by Amylin Pharmaceuticals, LLC. The MYALEPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, and leptin deficiency
myalept

General Information

Serial Number86043958
Word MarkMYALEPT
Filing DateWednesday, August 21, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 22, 2020
Registration Number4607022
Registration DateTuesday, September 16, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 14, 2014

Trademark Statements

Description of MarkThe mark consists of the word "myalept" with a shadowed leaf design over the "t".
Amendment to a Registration/Renewal CertificateIssue New Certificate to: Aegerion Pharmaceuticals, Inc. (Delaware Corporation) 101 Main Street, Suite 1850 Cambridge Massachusetts 02142
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, and leptin deficiency
Pseudo MarkMY ALEPT
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2013
Primary Code005
First Use Anywhere DateMonday, June 2, 2014
First Use In Commerce DateMonday, June 2, 2014

Trademark Owner History

Party NameAMRYT PHARMACEUTICALS INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDUBLIN 4
IE
Party NameAEGERION PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameAmylin Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Saturday, September 16, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, June 23, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 22, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, October 22, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 22, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 2, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 5, 2019NEW CERTIFICATE UNDER SECTION 7 ¿ PROCESSED
Thursday, October 31, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 25, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 23, 2019TEAS SECTION 7 REQUEST RECEIVED
Monday, September 16, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 18, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 21, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 6, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 29, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 10, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 10, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 15, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 16, 2014REGISTERED-PRINCIPAL REGISTER
Friday, August 15, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 14, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 23, 2014STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 1, 2014USE AMENDMENT FILED
Wednesday, July 23, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 1, 2014TEAS STATEMENT OF USE RECEIVED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 6, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 6, 2013ASSIGNED TO EXAMINER
Friday, August 30, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 24, 2013NEW APPLICATION ENTERED

Related Keywords

myalept pharmaceutical preparations leptin deficiency lipodystrophy prevention namely treatment lipoatrophy